ClinicalTrials.Veeva

Menu
H

Healthcare Research Network | Flossmoor, IL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Gefapixant
X0002
MK-7264
BGB-3111
CNTX-4975-05
MK-7264-030
Zanubrutinib
NRD135SE.1
Tyrosine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 8 total trials

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing,...

Enrolling
Migraine
Drug: Ubrogepant
Drug: Placebo for Ubrogepant

The primary objective of this study is to evaluate the safety of zanubrutinib (also known as BGB-3111) in chronic lymphocytic leukemia/small lymphocy...

Enrolling
Waldenstrom Macroglobulinemia
Marginal Zone Lymphoma
Drug: Zanubrutinib

Trial sponsors

Merck Sharp & Dohme (MSD) logo
J
AbbVie logo
BeiGene logo
C
Techfields logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems